Ultra-sensitive, tumor-informed ctDNA profiling in patients with gastroesophageal cancer and treated with pembrolizumab and longitudinal ctDNA kinetics
Publication
, Conference
Nixon, AB; McDaniel, L; Jia, J; Abbott, C; Howard, L; Brady, JC; Zhou, KI; Niedzwiecki, D; Chen, R; Strickler, JH; Boyle, SM; Uronis, HE
Published in: JOURNAL OF CLINICAL ONCOLOGY
2023
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2023
Volume
41
Issue
16_SUPPL
Start / End Page
4040 / 4040
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Nixon, A. B., McDaniel, L., Jia, J., Abbott, C., Howard, L., Brady, J. C., … Uronis, H. E. (2023). Ultra-sensitive, tumor-informed ctDNA profiling in patients with gastroesophageal cancer and treated with pembrolizumab and longitudinal ctDNA kinetics. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 41, pp. 4040–4040).
Nixon, Andrew B., Lee McDaniel, Jingquan Jia, Charles Abbott, Lauren Howard, John C. Brady, Katherine I. Zhou, et al. “Ultra-sensitive, tumor-informed ctDNA profiling in patients with gastroesophageal cancer and treated with pembrolizumab and longitudinal ctDNA kinetics.” In JOURNAL OF CLINICAL ONCOLOGY, 41:4040–4040, 2023.
Nixon AB, McDaniel L, Jia J, Abbott C, Howard L, Brady JC, et al. Ultra-sensitive, tumor-informed ctDNA profiling in patients with gastroesophageal cancer and treated with pembrolizumab and longitudinal ctDNA kinetics. In: JOURNAL OF CLINICAL ONCOLOGY. 2023. p. 4040–4040.
Nixon, Andrew B., et al. “Ultra-sensitive, tumor-informed ctDNA profiling in patients with gastroesophageal cancer and treated with pembrolizumab and longitudinal ctDNA kinetics.” JOURNAL OF CLINICAL ONCOLOGY, vol. 41, no. 16_SUPPL, 2023, pp. 4040–4040.
Nixon AB, McDaniel L, Jia J, Abbott C, Howard L, Brady JC, Zhou KI, Niedzwiecki D, Chen R, Strickler JH, Boyle SM, Uronis HE. Ultra-sensitive, tumor-informed ctDNA profiling in patients with gastroesophageal cancer and treated with pembrolizumab and longitudinal ctDNA kinetics. JOURNAL OF CLINICAL ONCOLOGY. 2023. p. 4040–4040.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2023
Volume
41
Issue
16_SUPPL
Start / End Page
4040 / 4040
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences